Could cutting more gut tissue stop Crohn's from coming back?

NCT ID NCT06856044

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether removing extra tissue (the mesentery) during standard Crohn's surgery is safe and helps prevent the disease from returning. About 30 adults with Crohn's disease who are already on biotherapy will undergo this procedure. The main goal is to see if the surgery causes more complications than usual, and if it lowers the chance of inflammation coming back within 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ileocolic resection with extended mesenteric resection (surgical procedure)
What this could lead to
If successful, this surgical technique could lower the chance of Crohn's disease coming back after surgery, reducing the need for repeat operations.
What could go wrong
This is a small, early pilot study with only 30 participants, so results may not apply to everyone. The surgery carries standard risks like bleeding or infection, and it's unclear if removing more tissue is truly better than the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Montpellier Hôpital St Eloi

    RECRUITING

    Montpellier, France

  • CHU de Nîmes

    RECRUITING

    Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.